Page last updated: 2024-11-02

pindolol and Heart Valve Diseases

pindolol has been researched along with Heart Valve Diseases in 2 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steinfath, M1
Lavicky, J1
Schmitz, W1
Scholz, H1
Döring, V1
Kalmár, P1
Bross, W1
Kustrzycki, A1
Olejak, B1
Bross, T1
Koltowski, R1
Masiak, M1

Other Studies

2 other studies available for pindolol and Heart Valve Diseases

ArticleYear
Changes in cardiac beta-adrenoceptors in human heart diseases: relationship to the degree of heart failure and further evidence for etiology-related regulation of beta 1 and beta 2 subtypes.
    Journal of cardiothoracic and vascular anesthesia, 1993, Volume: 7, Issue:6

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aortic Valve; Cardiomyopathy, Hypertrophic; Down-Reg

1993
[Hemodynamic effects of a new beta-adrenergic blocking agent].
    Kardiologia polska, 1973, Volume: 16, Issue:3

    Topics: Acid-Base Equilibrium; Adrenergic beta-Antagonists; Heart Valve Diseases; Hemodynamics; Humans; Pind

1973